利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

29 条记录 (耗时 0.05 秒)

    TREATMENT OF HODGKINS LYMPHOMA
    1.
    发明申请
    TREATMENT OF HODGKINS LYMPHOMA 审中-公开
    HODGKINS LYMPHOMA的治疗

    公开(公告)号：US20100189716A1

    公开(公告)日：2010-07-29

    申请号：US12593281

    申请日：2008-03-28

    申请人： Arturo Molina ,  Kandasamy Hariharan ,  Steffan Ho

    发明人： Arturo Molina ,  Kandasamy Hariharan ,  Steffan Ho

    IPC分类号： A61K39/395 ,  C12N5/00 ,  A61P35/00

    CPC分类号： C07K16/2827 ,  A61K2039/505 ,  C07K2317/24 ,  C07K2317/732 ,  C07K2317/76

    摘要： Compositions comprising CD80 antagonists and methods using these compositions are provided for the treatment of Hodgkins lymphoma. More particularly, the disclosed CD80 antagonists may be used to induce apoptosis or lysis of Hodgkins Reed-Sternberg (HRS) cells, or to inhibit HRS cell activities that promote tumor development or progression.

    摘要翻译： 提供包含CD80拮抗剂的组合物和使用这些组合物的方法用于治疗霍奇金淋巴瘤。 更具体地，所公开的CD80拮抗剂可以用于诱导霍奇金氏Reed-Sternberg（HRS）细胞的凋亡或裂解，或抑制促进肿瘤发展或进展的HRS细胞活性。

    Anti-IGF-1R Antibodies and Uses Thereof
    5.
    发明申请
    Anti-IGF-1R Antibodies and Uses Thereof 审中-公开
    抗IGF-1R抗体及其用途

    公开(公告)号：US20100099147A1

    公开(公告)日：2010-04-22

    申请号：US12559411

    申请日：2009-09-14

    申请人： Kandasamy Hariharan ,  Scott Glaser

    发明人： Kandasamy Hariharan ,  Scott Glaser

    IPC分类号： C12P21/00 ,  C07K16/00 ,  C07H21/00 ,  C12N15/63 ,  C12N5/00

    CPC分类号： C07K16/2863 ,  A61K2039/505 ,  C07K2317/21 ,  C07K2317/24 ,  C07K2317/33 ,  C07K2317/34 ,  C07K2317/41 ,  C07K2317/52 ,  C07K2317/524 ,  C07K2317/53 ,  C07K2317/55 ,  C07K2317/73 ,  C07K2317/76 ,  C07K2317/77 ,  C07K2317/92 ,  C07K2319/00

    摘要： The invention relates to antibodies which bind to insulin like growth factor receptor-1 (IGF-1R) and uses thereof, in particular in the diagnosis and treatment of cancer. Specific human and murine monoclonal antibodies which inhibit IGF-1R-mediated pro-survival and tumor proliferation pathways, and variants, fragments, and derivatives thereof are provided. Also provided are specific human and murine monoclonal antibodies which block the ability of the ligands, insulin like growth factor 1 (IGF-1) and insulin like growth factor 2 (IGF-2) to bind to IGF-1R, as well as fragments, variants and derivatives of such antibodies. The invention also includes polynucleotides encoding the above antibodies or fragments, variants or derivatives thereof, as well as vectors and host cells comprising such polynucleotides. The invention further includes methods of diagnosing and treating cancer using antibodies of the invention.

    摘要翻译： 本发明涉及结合胰岛素样生长因子受体-1（IGF-1R）的抗体及其用途，特别是癌症的诊断和治疗。 提供了抑制IGF-1R介导的原始存活和肿瘤增殖途径的特异性人和鼠单克隆抗体及其变体，片段及其衍生物。 还提供阻断配体，胰岛素样生长因子1（IGF-1）和胰岛素样生长因子2（IGF-2）与IGF-1R结合的能力的特异性人和鼠单克隆抗体，以及片段， 这些抗体的变体和衍生物。 本发明还包括编码上述抗体或其片段，变体或衍生物的多核苷酸，以及包含这种多核苷酸的载体和宿主细胞。 本发明还包括使用本发明的抗体诊断和治疗癌症的方法。

    THERAPEUTIC COMBINATIONS OF ANTI-IGF-1R ANTIBODIES AND OTHER COMPOUNDS
    6.
    发明申请
    THERAPEUTIC COMBINATIONS OF ANTI-IGF-1R ANTIBODIES AND OTHER COMPOUNDS 审中-公开
    抗IGF-1R抗体和其他化合物的治疗组合

    公开(公告)号：US20090291088A1

    公开(公告)日：2009-11-26

    申请号：US12422045

    申请日：2009-04-10

    申请人： Kandasamy Hariharan ,  Jianying Dong

    发明人： Kandasamy Hariharan ,  Jianying Dong

    IPC分类号： A61K39/395 ,  A61P35/00

    CPC分类号： C07K16/2863 ,  C07K2317/20 ,  C07K2317/21 ,  C07K2317/34 ,  C07K2317/55 ,  C07K2317/73 ,  C07K2317/76 ,  C07K2317/77 ,  C07K2317/92 ,  C07K2319/30

    摘要： The invention relates to methods of treatment using combination therapy wherein a variety of therapeutically useful compounds may be combined with antibodies which bind to insulin-like growth factor receptor-1 (IGF-1R). Specific human and murine monoclonal antibodies which inhibit IGF-1R-mediated pro-survival and tumor proliferation pathways, and variants, fragments, and derivatives thereof are provided. Also provided are specific human and murine monoclonal antibodies which block the ability of the ligands, insulin like growth factor 1 (IGF-1) and insulin like growth factor 2 (IGF-2) to bind to IGF-1R, as well as fragments, variants and derivatives of such antibodies. The invention also includes polynucleotides encoding the above antibodies or fragments, variants or derivatives thereof, as well as vectors and host cells comprising such polynucleotides. The invention particularly includes methods of treating cancer using combination therapies with IGF-1R antibodies.

    摘要翻译： 本发明涉及使用联合治疗的治疗方法，其中各种治疗有用的化合物可与与胰岛素样生长因子受体-1（IGF-1R）结合的抗体组合。 提供了抑制IGF-1R介导的原始存活和肿瘤增殖途径的特异性人和鼠单克隆抗体及其变体，片段及其衍生物。 还提供阻断配体，胰岛素样生长因子1（IGF-1）和胰岛素样生长因子2（IGF-2）与IGF-1R结合的能力的特异性人和鼠单克隆抗体，以及片段， 这些抗体的变体和衍生物。 本发明还包括编码上述抗体或其片段，变体或衍生物的多核苷酸，以及包含这种多核苷酸的载体和宿主细胞。 本发明特别包括使用与IGF-1R抗体的组合疗法治疗癌症的方法。